<DOC>
	<DOCNO>NCT00296894</DOCNO>
	<brief_summary>Patients randomize two group ( 1/1 ) one year : - 40 mg adalimumab subcutaneously ( sc ) every week - placebo The effect x-rays clinical parameter evaluate .</brief_summary>
	<brief_title>Study Evaluate Efficacy Adalimumab Patients With Erosive Osteoarthritis Interphalangeal Finger Joints</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Clear erosive image xray least one interphalangeal finger joint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>